Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Solitary Fibrous Tumor Treatment Market

4. Market Overview
4.1. Introduction & Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Solitary Fibrous Tumor Treatment Market Analysis and Forecast, 2017–2031

5. Market Outlook
5.1. Pipeline Analysis
5.2. COVID-19 Impact Analysis
5.3. Patients Population Data, 2018-2020

6. Global Solitary Fibrous Tumor Treatment Market Analysis and Forecast, by Treatment
6.1. Introduction & Definition
6.2. Global Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
6.2.1. Surgery
6.2.2. Radiation Therapy
6.2.3. Adjuvant Chemotherapy
6.3. Global Solitary Fibrous Tumor Treatment Market Attractiveness Analysis, by Treatment

7. Global Solitary Fibrous Tumor Treatment Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Global Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
7.2.1. Ambulatory Surgical Centers
7.2.2. Hospitals
7.2.3. Others
7.3. Global Solitary Fibrous Tumor Treatment Market Attractiveness Analysis, by End-user

8. Global Solitary Fibrous Tumor Treatment Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Solitary Fibrous Tumor Market Value (US$ Mn) Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Solitary Fibrous Tumor Treatment Market Attractiveness Analysis, by Region

9. North America Solitary Fibrous Tumor Treatment Market Analysis and Forecast
9.1. Introduction
9.2. North America Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
9.2.1. Surgery
9.2.2. Radiation Therapy
9.2.3. Adjuvant Chemotherapy
9.3. North America Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
9.3.1. Ambulatory Surgical Centers
9.3.2. Hospitals
9.3.3. Others
9.4. North America Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. North America Solitary Fibrous Tumor Market Attractiveness Analysis
9.5.1. By Treatment
9.5.2. By End-user
9.5.3. By Country

10. Europe Solitary Fibrous Tumor Treatment Market Analysis and Forecast
10.1. Introduction
10.2. Europe Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
10.2.1. Surgery
10.2.2. Radiation Therapy
10.2.3. Adjuvant Chemotherapy
10.3. Europe Solitary Fibrous Tumor Market Value (US$ Mn) Forecast, by End-user, 2017–2031
10.3.1. Ambulatory Surgical Centers
10.3.2. Hospitals
10.3.3. Others
10.4. Europe Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Solitary Fibrous Tumor Treatment Market Attractiveness Analysis
10.5.1. By Treatment
10.5.2. By End-user
10.5.3. By Country/Sub-region

11. Asia Pacific Solitary Fibrous Tumor Treatment Market Analysis and Forecast
11.1. Introduction
11.2. Asia Pacific Solitary Fibrous Tumor Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
11.2.1. Surgery
11.2.2. Radiation Therapy
11.2.3. Adjuvant Chemotherapy
11.3. Asia Pacific Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
11.3.1. Ambulatory Surgical Centers
11.3.2. Hospitals
11.3.3. Others
11.4. Asia Pacific Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Solitary Fibrous Tumor Market Attractiveness Analysis
11.5.1. By Treatment
11.5.2. By End-user
11.5.3. By Country/Sub-region

12. Latin America Solitary Fibrous Tumor Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Latin America Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
12.2.1. Surgery
12.2.2. Radiation Therapy
12.2.3. Adjuvant Chemotherapy
12.3. Latin America Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
12.3.1. Ambulatory Surgical Centers
12.3.2. Hospitals
12.3.3. Others
12.4. Latin America Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Solitary Fibrous Tumor Market Attractiveness Analysis
12.5.1. By Treatment
12.5.2. By End-user
12.5.3. By Country/Sub-region

13. Middle East & Africa Solitary Fibrous Tumor Treatment Market Analysis and Forecast
13.1. Introduction
13.2. Middle East & Africa Solitary Fibrous Tumor Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
13.2.1. Surgery
13.2.2. Radiation Therapy
13.2.3. Adjuvant Chemotherapy
13.3. Middle East & Africa Solitary Fibrous Tumor Market Value (US$ Mn) Forecast, by End-user, 2017–2031
13.3.1. Ambulatory Surgical Centers
13.3.2. Hospitals
13.3.3. Others
13.4. Middle East & Africa Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Solitary Fibrous Tumor Market Attractiveness Analysis
13.5.1. By Treatment
13.5.2. By End-user
13.5.3. By Country/Sub-region
13.5.4. Competition Landscape
13.6. Competition Landscape
13.7. Company Profiles
13.7.1. Pfizer, Inc.
13.7.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.7.1.2. Growth Strategies
13.7.1.3. SWOT Analysis
13.7.2. F. Hoffmann-La Roche Ltd.
13.7.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.7.2.2. Growth Strategies
13.7.2.3. SWOT Analysis
13.7.3. Eli Lilly and Company
13.7.3.1. Company Overview (HQ, Business Segments)
13.7.3.2. Growth Strategies
13.7.3.3. SWOT Analysis
13.7.4. Bayer AG
13.7.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.7.4.2. Growth Strategies
13.7.4.3. SWOT Analysis
13.7.5. Novartis AG
13.7.5.1. Company Overview (HQ, Business Segments)
13.7.5.2. Growth Strategies
13.7.5.3. SWOT Analysis



List of Figures

List of Figures

Figure 01: Global Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 02: Global Solitary Fibrous Tumor Treatment Market Value Share, by Region, 2020

Figure 03: Global Solitary Fibrous Tumor Treatment Market Value Share Analysis, by Treatment, 2020 and 2031

Figure 04: Global Solitary Fibrous Tumor Treatment Market Attractiveness Analysis, by Treatment, 2021–2031

Figure 05: Global Solitary Fibrous Tumor Treatment Market Revenue (US$ Mn), by Surgery, 2017–2031

Figure 06: Global Solitary Fibrous Tumor Treatment Market Revenue (US$ Mn), by Radiation Therapy, 2017–2031

Figure 07: Global Solitary Fibrous Tumor Treatment Market Revenue (US$ Mn), by Adjuvant Chemotherapy, 2017–2031

Figure 08: Global Solitary Fibrous Tumor Treatment Market Value Share Analysis, by End-user, 2020 and 2031

Figure 09: Global Solitary Fibrous Tumor Treatment Market Attractiveness Analysis, by End-user, 2021–2031

Figure 10: Global Solitary Fibrous Tumor Treatment Market Revenue (US$ Mn), by Hospitals, 2017–2031

Figure 11: Global Solitary Fibrous Tumor Treatment Market Revenue (US$ Mn), by Ambulatory Surgery Centers, 2017–2031

Figure 12: Global Solitary Fibrous Tumor Treatment Market Revenue (US$ Mn), by Others, 2017–2031

Figure 13: Global Solitary Fibrous Tumor Treatment Market Value Share Analysis, by Region, 2020 and 2031

Figure 14: Global Solitary Fibrous Tumor Treatment Market Attractiveness Analysis, by Region, 2021–2031

Figure 15: North America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 16: North America Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Country, 2020 and 2031

Figure 17: North America Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Country, 2021–2031

Figure 18: North America Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by End-user, 2020 and 2031

Figure 19: North America Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by End-user, 2021–2031

Figure 20: North America Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Treatment, 2020 and 2031

Figure 21: North America Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Treatment, 2021–2031

Figure 22: Europe Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 23: Europe Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 24: Europe Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 25: Europe Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by End-user, 2020 and 2031

Figure 26: Europe Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by End-user, 2021–2031

Figure 27: Europe Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Treatment, 2020 and 2031

Figure 28: Europe Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Treatment, 2021–2031

Figure 29: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 30: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 31: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 32: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by End-user, 2020 and 2031

Figure 33: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by End-user, 2021–2031

Figure 34: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Treatment, 2020 and 2031

Figure 35: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Treatment, 2021–2031

Figure 36: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 37: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 38: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 39: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Treatment, 2020 and 2031

Figure 40: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Treatment, 2021–2031

Figure 41: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by End-user, 2020 and 2031

Figure 42: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by End-user, 2021–2031

Figure 43: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 44: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 45: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 46: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by Treatment, 2020 and 2031

Figure 47: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by Treatment, 2021–2031

Figure 48: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Value Share Analysis, by End-user, 2020 and 2031

Figure 49: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Attractiveness Analysis, by End-user, 2021–2031

List of Tables

List of Tables

Table 01: Global Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 02: Global Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 03: Global Solitary Fibrous Tumor Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 04: North America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 05: North America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 06: North America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 07: Europe Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 08: Europe Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 10: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 11: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 12: Asia Pacific Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 13: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 15: Latin America Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 16: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 18: Middle East & Africa Solitary Fibrous Tumor (SFT) Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031